(To see other currencies, click on price)
MORE ABOUT THIS BOOK
Main description:
Expert physician-scientists and clinicians review those combinations of novel target agents classic chemotherapies that hold the most promise for the future of medical oncology, and detail their optimal sequence, pharmacokinetic interactions, and interaction with downstream cellular signals. The combinations run the gamut of targeted therapies against cell surface receptors (EGF-R and HER2), the cell cycle (the CDKs), signal transduction events (PKC and NF-kB), apoptosis (bcl-2), as well as focused therapies in ovarian cancer, hematologic diseases, and breast cancer. The authors emphasize novel translational approaches that are rapidly moving from the laboratory bench top to the patient's bedside for the future treatments in cancer therapy.
Contents:
Targeting of the EGFR As a Modulator of Cancer Chemotherapy
Jose Baselga
Cyclin-Dependent Kinase Inhibitors in Combination Chemotherapy
Manish A. Shah and Gary K. Schwartz
Development of Protein Kinase C and Cyclin-Dependent Kinase Inhibitors As Potentiators of Cytotoxic Drug Action in Leukemia
Steven Grant
Carboxyamidotriazole, an Inhibitor of Nonvoltage-Operated Calcium Entry: Single-Agent and Combination Therapy for Ovarian Carcinoma
Chad M. Michener and Elise C. Kohn
Targeted a-Particle Therapy: A Rational Approach to Drug Development in Hematologic Diseases and Solid Tumors
John M. Burke, David A. Scheinberg, and Joseph G. Jurcic
Pharmacological Modulation of Fluoropyrimidines: Building on the Lessons of the Past
Owen A. O'Connor
Development of Inhibitors of HER2 With Taxanes: New Directions in Breast Cancer Therapy
Shanu Modi, Monica N. Fornier, and Andrew D. Seidman
Targeting NF-kB to Increase the Activity of Cisplatin in Solid Tumors
Don S. Dizon, Carol Aghajanian, X. Jun Yan, and David R. Spriggs
Combinations of Chemotherapy and G3139, an Antisense Bcl-2 Oligonucleotide
Luba Benimetskaya, Sridhar Mani, and C. A. Stein
Use of Animal Models to Evaluate Signal Transduction Inhibitors As Modulators of Cytotoxic Therapy
Beverly A. Teicher
Index
PRODUCT DETAILS
Publisher: Springer (Humana Press Inc.)
Publication date: November, 2014
Pages: 296
Weight: 456g
Availability: Available
Subcategories: Oncology
From the same series
